Aeri stock recommendations
Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue ... Aerie Pharmaceuticals (AERI) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to loss of $1.73 per share a year ago. NASDAQ:AERI | Analyst Ratings